Comparative effectiveness research could get economic stimulus
House Democrats unveiled their $825 billion economic stimulus package, which will include $1.1 billion to be spent on comparative effectiveness research. The American Recovery and Reinvestment Bill of 2009, introduced Jan. 15 by the House Appropriations Committee, does not set up any separate comparative effectiveness research organization in connection with this financial outlay, but rather provides $700 million to the Agency for Healthcare Research and Quality and $400 million to the National Institutes of Health to carry out the research. The bill does, however, establish a Federal Coordinating Council for Comparative Effectiveness, with the purpose of working with federal agencies to coordinate or support research
You may also be interested in...
A lack of regulatory harmonization for dietary supplements in Asia is a big challenge facing companies operating in the region, according to experts from the Asia Regulatory Professionals Association. The ARPA is looking to start a conversation on the issue which the association hopes will lead to regulatory change.
The Chinese Society of Clinical Oncology (CSCO) annual meeting, against the background of the global pandemic, has one clear message that local researchers and players are pressing ahead to take a leadership role in cutting-edge cancer research globally.
Company is confident that data readout from pivotal trial could be ready before the end of 2020.